vimarsana.com
Home
Live Updates
Robert Bissonnette, MD: Safety Profile, Future Research on New Oral IL-23 Inhibitor for Psoriasis : vimarsana.com
Robert Bissonnette, MD: Safety Profile, Future Research on New Oral IL-23 Inhibitor for Psoriasis
During this segment of his interview, Bissonnette discussed safety data on JNJ-2113 for patients with plaque psoriasis and later went into future research topics.
Related Keywords
Robert Bissonnette ,
Innovaderm Research ,
Chief Executive Officer ,
Il 23 ,
Coral ,
Inhibitor ,
Jnj 2113 ,
Jnj ,
Bissonnette ,
Interview ,
Safety ,
Phase ,
Psoriasis ,
vimarsana.com © 2020. All Rights Reserved.